TABLE OF CONTENTS

1. Introduction

1.1 Market Definition

1.2 Scope

1.3 Research Assumptions

2. Industry Flowchart

3. Research Methodology

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

5. Porter’s 5 Forces Model

6. Pest Analysis

7. Nucleotide Market Segmentation, By Product

7.1 Introduction

7.2 Deoxy Nucleotides

7.3 Dideoxy nucleotides

7.4 Nucleotides for RNA Synthesis (rNTP)

7.5 Others

8. Nucleotide Market Segmentation, By Technology

8.1 Introduction

8.2 TaqMan Allelic Discrimination

8.3 Gene Chips & Microarrays

8.4 SNP By Pyrosequencing

8.5 Other

9. Nucleotide Market Segmentation, By Application

9.1 Introduction

9.2 Pharmaceuticals

9.3 Diagnostics Research

9.4 Food & Beverage Additive

9.5 Animal Feed Additive

9.6 Others

10. Regional Analysis

10.1 Introduction

10.2 North America

10.2.1 Trend Analysis

10.2.2 North America Nucleotide Market by Country

10.2.3 North America Nucleotide Market By Product

10.2.4 North America Nucleotide Market By Technology

10.2.5 North America Nucleotide Market By Application

10.2.6 USA

10.2.6.1 USA Nucleotide Market By Product

10.2.6.2 USA Nucleotide Market By Technology

10.2.6.3 USA Nucleotide Market By Application

10.2.7 Canada

10.2.7.1 Canada Nucleotide Market By Product

10.2.7.2 Canada Nucleotide Market By Technology

10.2.7.3 Canada Nucleotide Market By Application

10.2.8 Mexico

10.2.8.1 Mexico Nucleotide Market By Product

10.2.8.2 Mexico Nucleotide Market By Technology

10.2.8.3 Mexico Nucleotide Market By Application

10.3 Europe

10.3.1 Trend Analysis

10.3.2 Eastern Europe

10.3.2.1 Eastern Europe Nucleotide Market by Country

10.3.2.2 Eastern Europe Nucleotide Market By Product

10.3.2.3 Eastern Europe Nucleotide Market By Technology

10.3.2.4 Eastern Europe Nucleotide Market By Application

10.3.2.5 Poland

10.3.2.5.1 Poland Nucleotide Market By Product

10.3.2.5.2 Poland Nucleotide Market By Technology

10.3.2.5.3 Poland Nucleotide Market By Application

10.3.2.6 Romania

10.3.2.6.1 Romania Nucleotide Market By Product

10.3.2.6.2 Romania Nucleotide Market By Technology

10.3.2.6.4 Romania Nucleotide Market By Application

10.3.2.7 Hungary

10.3.2.7.1 Hungary Nucleotide Market By Product

10.3.2.7.2 Hungary Nucleotide Market By Technology

10.3.2.7.3 Hungary Nucleotide Market By Application

10.3.2.8 Turkey

10.3.2.8.1 Turkey Nucleotide Market By Product

10.3.2.8.2 Turkey Nucleotide Market By Technology

10.3.2.8.3 Turkey Nucleotide Market By Application

10.3.2.9 Rest of Eastern Europe

10.3.2.9.1 Rest of Eastern Europe Nucleotide Market By Product

10.3.2.9.2 Rest of Eastern Europe Nucleotide Market By Technology

10.3.2.9.3 Rest of Eastern Europe Nucleotide Market By Application

10.3.3 Western Europe

10.3.3.1 Western Europe Nucleotide Market by Country

10.3.3.2 Western Europe Nucleotide Market By Product

10.3.3.3 Western Europe Nucleotide Market By Technology

10.3.3.4 Western Europe Nucleotide Market By Application

10.3.3.5 Germany

10.3.3.5.1 Germany Nucleotide Market By Product

10.3.3.5.2 Germany Nucleotide Market By Technology

10.3.3.5.3 Germany Nucleotide Market By Application

10.3.3.6 France

10.3.3.6.1 France Nucleotide Market By Product

10.3.3.6.2 France Nucleotide Market By Technology

10.3.3.6.3 France Nucleotide Market By Application

10.3.3.7 UK

10.3.3.7.1 UK Nucleotide Market By Product

10.3.3.7.2 UK Nucleotide Market By Technology

10.3.3.7.3 UK Nucleotide Market By Application

10.3.3.8 Italy

10.3.3.8.1 Italy Nucleotide Market By Product

10.3.3.8.2 Italy Nucleotide Market By Technology

10.3.3.8.3 Italy Nucleotide Market By Application

10.3.3.9 Spain

10.3.3.9.1 Spain Nucleotide Market By Product

10.3.3.9.2 Spain Nucleotide Market By Technology

10.3.3.9.3 Spain Nucleotide Market By Application

10.3.3.10 Netherlands

10.3.3.10.1 Netherlands Nucleotide Market By Product

10.3.3.10.2 Netherlands Nucleotide Market By Technology

10.3.3.10.3 Netherlands Nucleotide Market By Application

10.3.3.11 Switzerland

10.3.3.11.1 Switzerland Nucleotide Market By Product

10.3.3.11.2 Switzerland Nucleotide Market By Technology

10.3.3.11.3 Switzerland Nucleotide Market By Application

10.3.3.12 Austria

10.3.3.12.1 Austria Nucleotide Market By Product

10.3.3.12.2 Austria Nucleotide Market By Technology

10.3.3.12.3 Austria Nucleotide Market By Application

10.3.3.13 Rest of Western Europe

10.3.3.13.1 Rest of Western Europe Nucleotide Market By Product

10.3.3.13.2 Rest of Western Europe Nucleotide Market By Technology

10.3.3.13.3 Rest of Western Europe Nucleotide Market By Application

10.4 Asia-Pacific

10.4.1 Trend Analysis

10.4.2 Asia-Pacific Nucleotide Market by Country

10.4.3 Asia-Pacific Nucleotide Market By Product

10.4.4 Asia-Pacific Nucleotide Market By Technology

10.4.5 Asia-Pacific Nucleotide Market By Application

10.4.6 China

10.4.6.1 China Nucleotide Market By Product

10.4.6.2 China Nucleotide Market By Technology

10.4.6.3 China Nucleotide Market By Application

10.4.7 India

10.4.7.1 India Nucleotide Market By Product

10.4.7.2 India Nucleotide Market By Technology

10.4.7.3 India Nucleotide Market By Application

10.4.8 Japan

10.4.8.1 Japan Nucleotide Market By Product

10.4.8.2 Japan Nucleotide Market By Technology

10.4.8.3 Japan Nucleotide Market By Application

10.4.9 South Korea

10.4.9.1 South Korea Nucleotide Market By Product

10.4.9.2 South Korea Nucleotide Market By Technology

10.4.9.3 South Korea Nucleotide Market By Application

10.4.10 Vietnam

10.4.10.1 Vietnam Nucleotide Market By Product

10.4.10.2 Vietnam Nucleotide Market By Technology

10.4.10.3 Vietnam Nucleotide Market By Application

10.4.11 Singapore

10.4.11.1 Singapore Nucleotide Market By Product

10.4.11.2 Singapore Nucleotide Market By Technology

10.4.11.3 Singapore Nucleotide Market By Application

10.4.12 Australia

10.4.12.1 Australia Nucleotide Market By Product

10.4.12.2 Australia Nucleotide Market By Technology

10.4.12.3 Australia Nucleotide Market By Application

10.4.13 Rest of Asia-Pacific

10.4.13.1 Rest of Asia-Pacific Nucleotide Market By Product

10.4.13.2 Rest of Asia-Pacific Nucleotide Market By Technology

10.4.13.3 Rest of Asia-Pacific Nucleotide Market By Application

10.5 Middle East & Africa

10.5.1 Trend Analysis

10.5.2 Middle East

10.5.2.1 Middle East Nucleotide Market by Country

10.5.2.2 Middle East Nucleotide Market By Product

10.5.2.3 Middle East Nucleotide Market By Technology

10.5.2.4 Middle East Nucleotide Market By Application

10.5.2.5 UAE

10.5.2.5.1 UAE Nucleotide Market By Product

10.5.2.5.2 UAE Nucleotide Market By Technology

10.5.2.5.3 UAE Nucleotide Market By Application

10.5.2.6 Egypt

10.5.2.6.1 Egypt Nucleotide Market By Product

10.5.2.6.2 Egypt Nucleotide Market By Technology

10.5.2.6.3 Egypt Nucleotide Market By Application

10.5.2.7 Saudi Arabia

10.5.2.7.1 Saudi Arabia Nucleotide Market By Product

10.5.2.7.2 Saudi Arabia Nucleotide Market By Technology

10.5.2.7.3 Saudi Arabia Nucleotide Market By Application

10.5.2.8 Qatar

10.5.2.8.1 Qatar Nucleotide Market By Product

10.5.2.8.2 Qatar Nucleotide Market By Technology

10.5.2.8.3 Qatar Nucleotide Market By Application

10.5.2.9 Rest of Middle East

10.5.2.9.1 Rest of Middle East Nucleotide Market By Product

10.5.2.9.2 Rest of Middle East Nucleotide Market By Technology

10.5.2.9.3 Rest of Middle East Nucleotide Market By Application

10.5.3 Africa

10.5.3.1 Africa Nucleotide Market by Country

10.5.3.2 Africa Nucleotide Market By Product

10.5.3.3 Africa Nucleotide Market By Technology

10.5.3.4 Africa Nucleotide Market By Application

10.5.3.5 Nigeria

10.5.3.5.1 Nigeria Nucleotide Market By Product

10.5.3.5.2 Nigeria Nucleotide Market By Technology

10.5.3.5.3 Nigeria Nucleotide Market By Application

10.5.3.6 South Africa

10.5.3.6.1 South Africa Nucleotide Market By Product

10.5.3.6.2 South Africa Nucleotide Market By Technology

10.5.3.6.3 South Africa Nucleotide Market By Application

10.5.3.7 Rest of Africa

10.5.3.7.1 Rest of Africa Nucleotide Market By Product

10.5.3.7.2 Rest of Africa Nucleotide Market By Technology

10.5.3.7.3 Rest of Africa Nucleotide Market By Application

10.6 Latin America

10.6.1 Trend Analysis

10.6.2 Latin America Nucleotide Market by country

10.6.3 Latin America Nucleotide Market By Product

10.6.4 Latin America Nucleotide Market By Technology

10.6.5 Latin America Nucleotide Market By Application

10.6.6 Brazil

10.6.6.1 Brazil Nucleotide Market By Product

10.6.6.2 Brazil Nucleotide Market By Technology

10.6.6.3 Brazil Nucleotide Market By Application

10.6.7 Argentina

10.6.7.1 Argentina Nucleotide Market By Product

10.6.7.2 Argentina Nucleotide Market By Technology

10.6.7.3 Argentina Nucleotide Market By Application

10.6.8 Colombia

10.6.8.1 Colombia Nucleotide Market By Product

10.6.8.2 Colombia Nucleotide Market By Technology

10.6.8.3 Colombia Nucleotide Market By Application

10.6.9 Rest of Latin America

10.6.9.1 Rest of Latin America Nucleotide Market By Product

10.6.9.2 Rest of Latin America Nucleotide Market By Technology

10.6.9.3 Rest of Latin America Nucleotide Market By Application

11. Company Profiles

11.1 CJ CheilJedang Corp.

11.1.1 Company Overview

11.1.2 Financial

11.1.3 Products/ Technology s Offered

11.1.4 The SNS View

11.2 Agilent Technologies Inc.

11.2.1 Company Overview

11.2.2 Financial

11.2.3 Products/ Technology s Offered

11.2.4 The SNS View

11.3 Star Lake Bioscience Co., Inc.

11.3.1 Company Overview

11.3.2 Financial

11.3.3 Products/ Technology s Offered

11.3.4 The SNS View

11.4 DSM Nutritional Products AG

11.4.1 Company Overview

11.4.2 Financial

11.4.3 Products/ Technology s Offered

11.4.4 The SNS View

11.5 Thermo Fisher Scientific Inc.

11.5.1 Company Overview

11.5.2 Financial

11.5.3 Products/ Technology s Offered

11.5.4 The SNS View

11.6 F. Hoffmann-La Roche Ltd.

11.6.1 Company Overview

11.6.2 Financial

11.6.3 Products/ Technology s Offered

11.6.4 The SNS View

11.7 MEIHUA HOLDINGS GROUP CO., LTD.

11.7.1 Company Overview

11.7.2 Financial

11.7.3 Products/ Technology s Offered

11.7.4 The SNS View

11.8 Biorigin

11.8.1 Company Overview

11.8.2 Financial

11.8.3 Products/ Technology s Offered

11.8.4 The SNS View

11.9 Promega Corporation

11.9.1 Company Overview

11.9.2 Financial

11.9.3 Products/ Technology s Offered

11.9.4 The SNS View

11.10 Lallemand Inc.

11.10.1 Company Overview

11.10.2 Financial

11.10.3 Products/ Technology s Offered

11.10.4 The SNS View

12. Competitive Landscape

12.1 Competitive Benchmarking

12.2 Market Share Analysis

12.3 Recent Developments

12.3.1 Industry News

12.3.2 Company News

12.3.3 Mergers & Acquisitions

13. Use Case and Best Practices

14. Conclusion